Literature DB >> 32767586

Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.

Ligong Lu1, Jun Jiang2, Meixiao Zhan1, Hui Zhang3, Qian-Ting Wang2, Sheng-Nan Sun2, Xiao-Kai Guo2, Hua Yin1, Yadong Wei4, Shi-You Li2, Jun O Liu4, Yong Li1, You-Wen He5.   

Abstract

Entities:  

Year:  2021        PMID： 32767586     DOI： 10.1002/hep.31502

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  12 in total

Review 1.  Hepatocyte ploidy and pathological mutations in hepatocellular carcinoma: impact on oncogenesis and therapeutics.

Authors:  Taiji Yamazoe; Taizo Mori; Sachiyo Yoshio; Tatsuya Kanto
Journal:  Glob Health Med       Date:  2020-10-31

Review 2.  Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?

Authors:  Ligong Lu; Hui Zhang; Meixiao Zhan; Jun Jiang; Hua Yin; Danielle J Dauphars; Shi-You Li; Yong Li; You-Wen He
Journal:  Sci China Life Sci       Date:  2020-12-01       Impact factor: 6.038

3.  TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes.

Authors:  Hyunseung Sun; Eunmi Kim; Jihye Ryu; Hyejin Lee; Eun-Ae Shin; Minhyeong Lee; Haesong Lee; Jeong-Hoon Lee; Jung-Hwan Yoon; Dae-Geun Song; Semi Kim; Jung Weon Lee
Journal:  Cell Mol Life Sci       Date:  2021-12-18       Impact factor: 9.261

4.  NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice.

Authors:  John C McVey; Benjamin L Green; Benjamin Ruf; Justin D McCallen; Simon Wabitsch; Varun Subramanyam; Laurence P Diggs; Bernd Heinrich; Tim F Greten; Chi Ma
Journal:  iScience       Date:  2022-02-01

Review 5.  Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.

Authors:  Zhuoyan Liu; Xuan Liu; Jiaxin Liang; Yixin Liu; Xiaorui Hou; Meichuan Zhang; Yongyin Li; Xiaotao Jiang
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

Review 6.  Application of Organoids in Carcinogenesis Modeling and Tumor Vaccination.

Authors:  Zeyu Wang; Shasha Zhao; Xiaolin Lin; Guanglong Chen; Jiawei Kang; Zhongping Ma; Yiming Wang; Zhi Li; Xiuying Xiao; Aina He; Dongxi Xiang
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

Review 7.  Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma.

Authors:  Marco Y W Zaki; Ahmed M Fathi; Samara Samir; Nardeen Eldafashi; Kerolis Y William; Maiiada Hassan Nazmy; Moustafa Fathy; Upkar S Gill; Shishir Shetty
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.575

8.  Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis.

Authors:  Hongjuan You; Dongchen Yuan; Yanwei Bi; Ning Zhang; Qi Li; Tao Tu; Xiao Wei; Qi Lian; Tong Yu; Delong Kong; Xiaoying Yang; Xiangye Liu; Xiaomei Liu; Fanyun Kong; Kuiyang Zheng; Renxian Tang
Journal:  Cell Commun Signal       Date:  2021-03-15       Impact factor: 5.712

Review 9.  CD8+ T Cell Responses during HCV Infection and HCC.

Authors:  Maike Hofmann; Catrin Tauber; Nina Hensel; Robert Thimme
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241

10.  LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma.

Authors:  Fahui Liu; Wanyun Hou; Jiadong Liang; Lilan Zhu; Chunying Luo
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.